Background morbidity in HIV vaccine trial participants from various geographic regions as assessed by unsolicited adverse events.
Beteiligte Einrichtungen
Abstract
Recently, more clinical trials are being conducted in Africa and Asia, therefore, background morbidity in the respective populations is of interest. Between 2000 and 2007, the International AIDS Vaccine Initiative sponsored 19 Phase 1 or 2A preventive HIV vaccine trials in the US, Europe, Sub-Saharan Africa and India, enrolling 900 healthy HIV-1 uninfected volunteers.
Bibliografische Daten
| Originalsprache | Englisch |
|---|---|
| Aufsatznummer | 5 |
| Status | Veröffentlicht - 2012 |
| pubmed | 22634443 |
|---|
